Center for Digestive and Liver Diseases, Inc.  © 2013  |  Privacy policy

like us


Crohn's Disease


Protocol RHB-104-01


The investigators hypothesize that RHB-104 will have greater efficacy than placebo in Crohn's disease


A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease




I am interested in more information about this study.